Skip to content
naulon
Not checkedNot checked for notices yet.

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in comparison with Idiopathic Interstitial pneumonia

Fujiko Someya, Naoki Mugii

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine · 2013

doi:10.4137/ccrpm.s10764 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Although the relationship between muscle strength and exercise capacity has been demonstrated in dermatomyositis without lung dysfunction, little is known about the association between exercise capacity and interstitial lung disease in dermatomyositis. Eleven patients with dermatomyositis with interstitial lung disease without the manifestation of muscle weakness and 12 patients with idiopathic interstitial pneumonia underwent the 6-minute walk test (6MWT). PaO 2 , creatine kinase, percentage predicted 6MWT distance (6MWD%), and SpO 2 at rest were similar between patients. Percentage predicted vital capacity, carbon monoxide diffusing capacity (DL CO %), and SpO 2 after 6MWT were higher and exertional dyspnea was lower in patients with dermatomyositis than in patients with idiopathic interstitial pneumonia. SpO 2 after 6MWT was positively correlated with 6MWD% in patients with dermatomyositis, while DL CO % and PaO 2 were positively correlated with 6MWD% in patients with idiopathic interstitial pneumonia. Lung dysfunction in dermatomyositis might not be a major limitation factor in exercise capacity.

Abstract licence: CC BY-NC

References21

    21 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.